Study title:
Sodium cromoglycate therapy in wheezing infant : preliminary evidence of beneficial outcome at early school age - Kotaniemi-Syrjanen A, Reijonen TM, Korhonen K, Korppi M - 2005 (Pediatr Int 2005; 627-34)
Publication in CES clinical expert statement - Bruno Verdoncq - 28/08/07Sodium cromoglycate therapy in wheezing infant : preliminary evidence of beneficial outcome at early school age - Kotaniemi-Syrjanen A, Reijonen TM, Korhonen K, Korppi M - 2005 (Pediatr Int 2005; 627-34)
Publication in CES clinical expert statement - Bruno Verdoncq - 28/08/07
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Respiratory Tract Diseases
|
Brands: Please see report, Please see report, Please see report |
MAH holders: Please see report, Please see report, Please see report, Please see report |
Assessment: |
Active substance: CROMOGLICIC ACID |
ATC code: |
Document link:
|
Document date:
|
Study number: - |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
Y
|
-
|
-
|